Risks and Challenges in Pharmaceutical Manufacturing & Distribution
Pharmaceutical manufacturers and distributors face unique risks in controlled substance management. DEA expectations continue to increase. Enforcement actions carry civil and criminal exposure. A single gap in recordkeeping or suspicious order monitoring can trigger intense scrutiny.
Our team understands this environment. We have built, tested, and defended programs in high-risk settings. We take on matters that other firms step away from.
Key risk areas include:
- DEA inspections and enforcement actions that can disrupt operations and put registrations at risk
- Recordkeeping violations for production, shipment, returns, destruction, and reporting of controlled substances
- Diversion risks in storage, handling, suspicious order monitoring, and downstream customer controls
- Fines and penalties that can reach millions of dollars and trigger long-term monitoring agreements